Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Pilgaonkar v. Kitov Pharmaceuticals Holdings Ltd et al
Case Number:
1:17-cv-00917
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
-
July 30, 2018
Israeli Pharma Co. To Pay $2M To End Stock-Drop Suit
Shareholders in Israeli pharmaceutical company Kitov Pharmaceuticals asked a New York federal judge on Friday to approve a $2 million deal to settle allegations the company and its CEO falsified late-stage trial results for a hypertension treatment and forced stocks to drop.
-
March 21, 2018
Israeli Pharma Co., CEO Can't Escape Stock-Drop Suit
A New York federal judge on Tuesday dismissed investors' claims against the chief financial officer of an Israel-based pharmaceutical company but said the company and its CEO are still on the line for allegedly misleading investors about falsified late-stage trial results for a hypertension treatment.
-
August 03, 2017
Israeli Pharma Co. Wants NY Stock-Drop Class Suit Tossed
An Israel-based pharmaceutical company urged a New York federal judge Wednesday to toss a proposed class action alleging it falsified late-stage trial results for a hypertension treatment and subsequently caused the company's share price to drop, saying the investors haven’t sufficiently demonstrated how the purported falsification occurred.
-
June 15, 2017
Rosen Firm Ends Bid To Lead NY Pharma Stock-Drop Class
The Rosen Law Firm has agreed to withdraw its application to steer a potential New York stock-drop class accusing an Israeli drug company of securities fraud after the defense said its representation of a competing California class in a similar case was a conflict, an order docketed Wednesday says.
-
May 22, 2017
Pharma Co. Says Rosen Firm's Conflicted In Stock Drop Case
An Israeli drug company accused of securities fraud told a New York federal judge Friday that the Rosen Law Firm shouldn't be allowed to represent investors in the case because it represents a competing class of shareholders in a similar case.
-
February 08, 2017
Pharma Co. Investors Sue After CEO Detained Over Drug Trial
Kitov Pharmaceuticals Holdings Ltd. investors hit the Israel-based company with a suit in New York federal court on Tuesday over a stock drop that allegedly occurred once news broke that its CEO was detained on suspicion of publishing misleading information about drug testing.